Related Experiment Video
Updated: May 27, 2026
05:05
A Modified Precipitation Method to Isolate Urinary Exosomes
Published on: January 16, 2015
Uromodulin exclusion list improves urinary exosomal protein identification
Thomas F Hiemstra1, Philip D Charles, Svenja S Hester
1Department of Medical Genetics and Division of Renal Medicine, University of Cambridge, Cambridge, United Kingdom.
Journal of Biomolecular Techniques : JBT
|December 2, 2011
Summary
This study introduces an exclusion list (ExL) method to improve mass spectrometry (MS) analysis of urine exosomes. This technique enhances the identification of low-abundance urinary exosomal proteins, crucial for renal disease biomarker discovery.
Area of Science:
- Proteomics
- Biomarker Discovery
- Mass Spectrometry
Background:
- Urine exosomes are promising biomarkers for renal disease.
- High abundance of uromodulin protein in urine exosomes limits mass spectrometry (MS) sensitivity.
- Current uromodulin depletion methods are laborious and may remove valuable biomarkers.
Purpose of the Study:
- To develop a more efficient method for increasing the depth of urinary exosomal proteome coverage using MS.
- To overcome limitations posed by abundant urinary proteins like uromodulin.
- To reduce the need for time-consuming uromodulin depletion.
Main Methods:
- Application of a fixed exclusion list (ExL) of uromodulin-related peptide ions during tandem MS analysis.
- Utilizing high-sensitivity mass spectrometric analysis.
- Combining ExL with dynamic exclusion techniques.
Main Results:
- The ExL method increased urinary exosomal protein identifications by 29.7%, from 222 to 288 proteins.
- Identified a previously uncharacterized set of lower-abundance proteins.
- Demonstrated that ExL effectively enhances proteome coverage without uromodulin depletion.
Conclusions:
- A fixed ExL combined with conventional MS methods significantly increases the depth of urinary exosomal protein identification.
- This approach offers a more efficient alternative to uromodulin depletion for exosomal proteomic studies.
- The ExL strategy enhances the potential for discovering novel renal disease biomarkers in urine exosomes.
